Literature DB >> 9796633

Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.

A Zeleniuch-Jacquotte1, H Adlercreutz, A Akhmedkhanov, P Toniolo.   

Abstract

We examined the distribution and long-term reliability of serum measurements of the two main human lignans, enterolactone and enterodiol, and the isoflavonoid phytoestrogens daidzein, genistein, equol, and O-Desmethylangolensin in the New York University Women's Health Study, a prospective cohort study of sex hormones and breast cancer. Serum samples collected at three yearly visits in 30 premenopausal and 30 postmenopausal women who had not been diagnosed with cancer or cardiovascular disease were included in the study. Assays were carried out by ion-exchange chromatography and capillary gas chromatography-mass spectrometry. Levels of isoflavonoid phytoestrogens were low, often at or below the sensitivity level of the assay. The reliability coefficients for these compounds were also low (< or =0.30). The median levels of enterodiol and enterolactone were 1.52 nmol/liter and 20.2 nmol/liter, respectively, and were comparable with the levels observed in omnivorous Finnish women living in the Helsinki area. A substantial number of women, though, had fairly high levels: for instance, 15% of the assays showed levels of enterolactone greater than the mean level observed in vegetarian Finnish women, i.e., 89.1 nmol/liter (H. Adlercreutz et al., Cancer Detec. Prev., 18: 259-271, 1994). The reliability coefficient of a single measurement of enterolactone was moderately high (0.55), suggesting that serum measurements of this compound could be a useful tool in prospective epidemiological studies with access to repeated blood or serum specimens. For instance, the reliability coefficient of the average of three measurements of enterolactone would be 0.79, a level considered acceptable in light of the other sources of error that are present in epidemiological studies (W. Willett, Stat. Med., 8: 1031-1040, 1989).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796633

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies.

Authors:  Joanne Kotsopoulos; Shelley S Tworoger; Hannia Campos; Fung-Lung Chung; Charles V Clevenger; Adrian A Franke; Christos S Mantzoros; Vincent Ricchiuti; Walter C Willett; Susan E Hankinson; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

2.  Dietary flavonol intake is associated with age of puberty in a longitudinal cohort of girls.

Authors:  Nancy A Mervish; Eliza W Gardiner; Maida P Galvez; Larry H Kushi; Gayle C Windham; Frank M Biro; Susan M Pinney; Michael E Rybak; Susan L Teitelbaum; Mary S Wolff
Journal:  Nutr Res       Date:  2013-05-31       Impact factor: 3.315

3.  Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer.

Authors:  A K Eriksen; C Kyrø; N Nørskov; A K Bolvig; J Christensen; A Tjønneland; K Overvad; R Landberg; A Olsen
Journal:  Eur J Clin Nutr       Date:  2017-04-05       Impact factor: 4.016

4.  Reliability of serum and urinary isoflavone estimates.

Authors:  Gary E Fraser; Adrian A Franke; Karen Jaceldo-Siegl; Hannelore Bennett
Journal:  Biomarkers       Date:  2010-03       Impact factor: 2.658

5.  Environmental exposures and puberty in inner-city girls.

Authors:  Mary S Wolff; Julie A Britton; Lisa Boguski; Sarah Hochman; Nell Maloney; Nicole Serra; Zhisong Liu; Gertrud Berkowitz; Signe Larson; Joel Forman
Journal:  Environ Res       Date:  2008-05-13       Impact factor: 6.498

6.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Authors:  Mary K Townsend; Clary B Clish; Peter Kraft; Chen Wu; Amanda L Souza; Amy A Deik; Shelley S Tworoger; Brian M Wolpin
Journal:  Clin Chem       Date:  2013-07-29       Impact factor: 8.327

7.  Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.

Authors:  Ruth C Travis; Naomi E Allen; Paul N Appleby; Alison Price; Rudolf Kaaks; Jenny Chang-Claude; Heiner Boeing; Krasimira Aleksandrova; Anne Tjønneland; Nina Føns Johnsen; Kim Overvad; J Ramón Quirós; Carlos A González; Esther Molina-Montes; Maria José Sánchez; Nerea Larrañaga; José María Huerta Castaño; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Antonia Trichopoulou; Tina Karapetyan; Snorri Bjorn Rafnsson; Domenico Palli; Vittorio Krogh; Rosario Tumino; Paolo Vineis; H Bas Bueno-de-Mesquita; Pär Stattin; Mattias Johansson; Veronika Fedirko; Teresa Norat; Afshan Siddiq; Elio Riboli; Timothy J Key
Journal:  Cancer Causes Control       Date:  2012-05-22       Impact factor: 2.506

8.  Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.

Authors:  Aurora Perez-Cornago; Paul N Appleby; Heiner Boeing; Leire Gil; Cecilie Kyrø; Fulvio Ricceri; Neil Murphy; Antonia Trichopoulou; Konstantinos K Tsilidis; Kay-Tee Khaw; Robert N Luben; Randi E Gislefoss; Hilde Langseth; Isabel Drake; Emily Sonestedt; Peter Wallström; Pär Stattin; Anders Johansson; Rikard Landberg; Lena Maria Nilsson; Kotaro Ozasa; Akiko Tamakoshi; Kazuya Mikami; Tatsuhiko Kubo; Norie Sawada; Shoichiro Tsugane; Timothy J Key; Naomi E Allen; Ruth C Travis
Journal:  Int J Cancer       Date:  2018-09-29       Impact factor: 7.396

9.  Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.

Authors:  Heather Ward; Gaelle Chapelais; Gunter G C Kuhnle; Robert Luben; Kay-Tee Khaw; Sheila Bingham
Journal:  Breast Cancer Res       Date:  2008-04-17       Impact factor: 6.466

10.  Circulating enterolactone and risk of breast cancer: a prospective study in New York.

Authors:  A Zeleniuch-Jacquotte; H Adlercreutz; R E Shore; K L Koenig; I Kato; A A Arslan; P Toniolo
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.